<DOC>
	<DOCNO>NCT03086850</DOCNO>
	<brief_summary>Main objective : To assess effect daily physical activity promotion pedometer 12 month apnea-hypopnea index ( AHI ) patient mild moderate obstructive sleep apnea ( OSA ) . Study patient . Subjects 30-80 year old diagnosis mild-moderate OSA ( AHI : 5-30 predominance obstructive event [ &gt; 80 % ) ] . Design . Randomized , parallel open-label clinical trial , control conventional treatment . Intervention : Patients randomize ( 1:1 ) control group [ treatment follow-up accord conventional clinical practice ] intervention group [ addition conventional treatment follow-up , patient receive pedometer measure number step walk daily . Based cumulative step count day mean value since last visit , patient receive task increase step per day next appointment accord next protocol ( &lt; 6000 steps/day : increase 3000 steps/day ; 6000 - 10000 steps/day : reach 10000 steps/day ; &gt; 10000 steps/day : maintain increase step ) . Measurements . At , 12 , 24 52 week randomization , follow determination make : anthropometric characteristic ; clinical evaluation ( smoke history , sleep symptom , comorbidities , current medication ) ; questionnaire ( ESS , FOSQ , SF-12 , EuroQoL iPAZ ) ; heart rate blood pressure ; analytical determination ( HbA1c , HOMA index , cholesterol , LDL-cholesterol , HDL-cholesterol , triglyceride , homocysteine , NT-proBNP hsCRP ) ; plasmatic biomarkers ( 8-isoprostane , IL1beta , IL6 , IL8 TNFalpha ) ; evaluation daily physical activity use accelerometer .</brief_summary>
	<brief_title>Long-term Effect Physical Activity Promotion Clinical Characteristics Vascular Risk Patients With Mild-moderate Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Age 30 80 year Diagnosis mildmoderate obstructive sleep apnea [ apneahypopnea index 530 h1 ] polysomnography respiratory polygraphy Predominance obstructive event ( &gt; 80 % ) Signature inform consent Previous diagnosis chronic obstructive pulmonary disease , asthma , diffuse interstitial lung disease chest wall disease . Evidence central apnea , hypoventilation syndrome respiratory failure Previous diagnosis refractory arterial hypertension , congestive heart failure , ischemic heart disease cerebrovascular disease . Neurological osteoarticular limitation prevents ambulation . Professional driver occupational risk respiratory Previous treatment CPAP Participation another clinical trial 30 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>